Bimi International Medical Inc is a pharmaceutical retailers business based in the US. Bimi International Medical shares (BIMI) are listed on the NASDAQ and all prices are listed in US Dollars. Bimi International Medical employs 524 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $0.63 |
|---|---|
| 52-week range | $0.40 - $13.35 |
| 50-day moving average | $0.72 |
| 200-day moving average | $2.17 |
| Wall St. target price | $12.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-4.88 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.6255 from 2022-07-01
| 1 week (2022-06-24) | -3.77% |
|---|---|
| 1 month (2022-06-02) | 45.47% |
| 3 months (2022-03-31) | -54.67% |
| 6 months (2021-12-31) | 22.65% |
| 1 year (2021-07-02) | -51.51% |
|---|---|
| 2 years (2020-07-02) | -70.36% |
| 3 years (2019-07-02) | 2.56 |
| 5 years (2017-06-30) | 4.55 |
| Revenue TTM | $29.9 million |
|---|---|
| Gross profit TTM | $4.6 million |
| Return on assets TTM | -10.49% |
| Return on equity TTM | -181.55% |
| Profit margin | -114.9% |
| Book value | $1.28 |
| Market capitalisation | $6.7 million |
TTM: trailing 12 months
We're not expecting Bimi International Medical to pay a dividend over the next 12 months.
Bimi International Medical's shares were split on a 1:5 basis on 2 February 2022. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bimi International Medical shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Bimi International Medical shares which in turn could have impacted Bimi International Medical's share price.
Over the last 12 months, Bimi International Medical's shares have ranged in value from as little as $0.4 up to $13.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bimi International Medical's is 0.2377. This would suggest that Bimi International Medical's shares are less volatile than average (for this exchange).
BIMI International Medical Inc. , together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.